Lyell Immunopharma Inc Cash Flow Reinvestment Rate
Lyell Immunopharma Inc cash flow reinvestment rate. Lyell Immunopharma Inc (LYEL) has a Cash Flow Reinvestment Rate of 10.70x as of December 2019, reinvesting $422.43 Million (capex $16.05 Million plus investments $-406.39 Million) from operating cash flow of $39.47 Million. Explore Lyell Immunopharma Inc (LYEL) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Lyell Immunopharma Inc (2019–2019)
Cash flow reinvestment rate of Lyell Immunopharma Inc from 2019 to 2019. Historical reinvestment intensity for Lyell Immunopharma Inc across 1 annual periods. Explore Lyell Immunopharma Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Lyell Immunopharma Inc Cash Flow Reinvestment Rate by Year (2019–2019)
Lyell Immunopharma Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Lyell Immunopharma Inc. For the full cash flow conversion analysis, see LYEL cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 10.70x | $422.43 Million | $39.47 Million | $16.05 Million | — |